Inhibikase Therapeutics, Inc.

Institutional Ownership & Holdings Analysis

About
CIK: 0001750149
Type: CompanyHolders: 51Top 10: 93.0%Value: $112.6B

inhibikase-therapeutics is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.

Top Institutional Holders
#1Sands Capital Ventures, LLC
As of 2025-03-31
Value:$24.0M
#2Soleus Capital Management, L.P.
As of 2025-03-31
Value:$13.9M
#3Fairmount Funds Management LLC
As of 2025-03-31
Value:$13.4M
#4PERCEPTIVE ADVISORS LLC
As of 2025-03-31
Value:$13.0M
#5COMMODORE CAPITAL LP
As of 2025-03-31
Value:$11.7M
#6ADAR1 Capital Management, LLC
As of 2025-03-31
Value:$11.2M
#7VANGUARD GROUP INC
As of 2025-03-31
Value:$6.2M
#8Nantahala Capital Management, LLC
As of 2025-03-31
Value:$4.8M
#9Blackstone Inc.
As of 2025-03-31
Value:$4.5M
#10Stonepine Capital Management, LLC
As of 2025-03-31
Value:$2.0M
#11MILLENNIUM MANAGEMENT LLC
As of 2025-03-31
Value:$2.0M
#12SUSQUEHANNA INTERNATIONAL GROUP, LLP
As of 2025-03-31
Value:$1.1M
#13BlackRock, Inc.
As of 2025-03-31
Value:$928.5K
#14GEODE CAPITAL MANAGEMENT, LLC
As of 2025-03-31
Value:$711.3K
#15GOLDMAN SACHS GROUP INC
As of 2025-03-31
Value:$363.6K
#16BLAIR WILLIAM & CO/IL
As of 2025-03-31
Value:$341.5K
#17JANE STREET GROUP, LLC
As of 2025-03-31
Value:$254.6K
#18BARCLAYS PLC
As of 2025-03-31
Value:$184.0K
#19BALYASNY ASSET MANAGEMENT L.P.
As of 2025-03-31
Value:$177.7K
#20HRT FINANCIAL LP
As of 2025-03-31
Value:$144.0K
Total Institutional Holders:51
Top 10 Holders Own:93.0%